Literature DB >> 11670187

Unusual Ring Systems Containing Indium. Synthesis and Structure of the First Mercuraindacycles.

François P. Gabbaï1, Annette Schier, Jürgen Riede, Alexander Sladek, Hans W. Görlitzer.   

Abstract

The mercuraindacycles bis(&mgr;-1,8-naphthalenediyl)mercury(II)(bis(tetrahydrofuran)chloroindium(III)) (5) and bis(&mgr;-1,8-naphthalenediyl)mercury(II)(bis(tetrahydrofuran)bromoindium(III)) (7) are the products of the reaction of indium(I) halides with 1,8-naphthalenediylbis(mercury(II) halides). Their formation involves a partial transmetalation followed by a spontaneous ring closure. Compounds 5 and 7 have been characterized by (1)H, (13)C, and (199)Hg NMR spectroscopy. The X-ray crystal structures of 5.(InCl(3)(THF)(3)) and 7 have been determined. Compound 5 crystallizes as an InCl(3)(THF)(3) adduct in the monoclinic space group P2(1)/c with a = 17.529(2) Å, b = 8.954(1) Å, c = 27.704(1) Å, beta = 107.02(1) degrees, V = 4157.8(7) Å(3), and Z = 4. Compound 7 crystallizes in the orthorhombic space group P2(1)2(1)2(1) with a = 8.368(1) Å, b = 15.357(1) Å, c = 19.446(1) Å, V = 2499.0(4) Å(3), and Z = 4. In both structures, the eight-membered dimetallacycles adopt a twisted conformation with conspicuously short In. Hg transannular distances. Finally, the X-ray crystal structure of the diindacycle bis(&mgr;-1,8-naphthalenediyl)bis(bis(tetrahydrofuran)chloroindium(III)) (8) is reported. This compound is isolated as a low-yield side product in the synthesis of 5. Compound 8 crystallizes in the tetragonal space group P4/n with a = 19.492(1) Å, c = 10.432 Å, V = 3963.5(5) Å(3), and Z = 4.

Entities:  

Year:  1997        PMID: 11670187     DOI: 10.1021/ic970241g

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  1 in total

1.  Chemical-Shift Standards for 199Hg NMR Spectroscopy, 25 Years Later.

Authors:  David Z Zee; Christopher P Singer; Thomas V O'Halloran
Journal:  Inorg Chem       Date:  2022-08-22       Impact factor: 5.436

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.